Literature DB >> 24218447

Response to letter regarding article, "Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States".

Gautam R Shroff1, Craig A Solid, Charles A Herzog.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24218447     DOI： 10.1161/CIRCULATIONAHA.113.005706

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Peripheral blood-derived endothelial progenitor cell therapy prevented deterioration of chronic kidney disease in rats.

Authors:  Tien-Hung Huang; Yen-Ta Chen; Pei-Hsun Sung; Hsin-Ju Chiang; Yung-Lung Chen; Han-Tan Chai; Sheng-Ying Chung; Tzu-Hsien Tsai; Chih-Chao Yang; Chih-Hung Chen; Yi-Ling Chen; Hsueh-Wen Chang; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

2.  Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial.

Authors:  Mel S Lee; Fan-Yen Lee; Yung-Lung Chen; Pei-Hsun Sung; Hsin-Ju Chiang; Kuan-Hung Chen; Tien-Hung Huang; Yi-Ling Chen; John Y Chiang; Tsung-Cheng Yin; Hsueh-Wen Chang; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-03-14

3.  Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open-label, controlled phase II clinical trial.

Authors:  Chih-Chao Yang; Pei-Hsun Sung; Ben-Chung Cheng; Yi-Chen Li; Yi-Ling Chen; Mel S Lee; Hon-Kan Yip
Journal:  Stem Cells Transl Med       Date:  2020-04-16       Impact factor: 6.940

4.  Overexpression of miR-19a and miR-20a in iPS-MSCs preserves renal function of chronic kidney disease with acute ischaemia-reperfusion injury in rat.

Authors:  Mel S Lee; Hon-Kan Yip; Chih-Chao Yang; John Y Chiang; Tien-Hung Huang; Yi-Chen Li; Kuan-Hung Chen; Pei-Hsun Sung
Journal:  J Cell Mol Med       Date:  2021-06-23       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.